Literature DB >> 19660442

Determination of high-affinity choline uptake (HACU) and choline acetyltransferase (ChAT) activity in the same population of cultured cells.

Balmiki Ray1, Jay R Simon, Debomoy K Lahiri.   

Abstract

Cholinergic neurons are a major constituent of the mammalian central nervous system. Acetylcholine, the neurotransmitter used by cholinergic neurons, is synthesized from choline and acetyl CoA by the enzymatic action of choline acetyltransferase (ChAT). The transport of choline into the cholinergic neurons, which results in synthesis of ACh, is hemicholinium-sensitive and is referred to as high-affinity choline uptake (HACU). Thus, the formation of acetylcholine in cholinergic neurons largely depends on both the levels of choline being transported into the cells from the extracellular space and the activity of ChAT. Several methods were described previously to measure HACU and ChAT simultaneously in synaptosomes, but the same for cultured cells is lacking. We describe a procedure to measure HACU and ChAT at the same time in cultured cells by simple techniques employing radionuclides. In this procedure, we determined quantitatively hemicholinium-sensitive choline uptake and ChAT enzyme activity in a small number of differentiated human neuroblastoma (SK-N-SH) cells. We also determined the kinetics of choline uptake in the SK-N-SH cells. We believe that these simple methods can be used for neurochemical and drug discovery studies in several models of neurodegenerative disorders including Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19660442      PMCID: PMC2868359          DOI: 10.1016/j.brainres.2009.07.096

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

Review 1.  A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease.

Authors:  Debomoy K Lahiri; Martin R Farlow; Kumar Sambamurti; Nigel H Greig; Ezio Giacobini; Lon S Schneider
Journal:  Curr Drug Targets       Date:  2003-02       Impact factor: 3.465

2.  Impulse-flow regulation of high affinity choline uptake in brain cholinergic nerve terminals.

Authors:  J R Simon; M G Kuhar
Journal:  Nature       Date:  1975-05-08       Impact factor: 49.962

Review 3.  Rivastigmine for Alzheimer's disease.

Authors:  Jacqueline Birks; John Grimley Evans; Vasso Iakovidou; Magda Tsolaki; Francesca E Holt
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

4.  Sodium-dependent high affinity choline uptake: a regulatory step in the synthesis of acetylcholine.

Authors:  J R Simon; S Atweh; M J Kuhar
Journal:  J Neurochem       Date:  1976-05       Impact factor: 5.372

Review 5.  Recent developments in biochemical investigations of cholinergic transmission.

Authors:  F Fonnum
Journal:  Brain Res       Date:  1973-11-23       Impact factor: 3.252

6.  Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells.

Authors:  L J Wainwright; A Lasorella; A Iavarone
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

7.  Promoter activity of the beta-amyloid precursor protein gene is negatively modulated by an upstream regulatory element.

Authors:  D K Lahiri; C Nall; Y W Ge
Journal:  Brain Res Mol Brain Res       Date:  1999-07-23

8.  Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line.

Authors:  Marina Pizzi; Flora Boroni; Andrea Bianchetti; Costantinos Moraitis; Ilenia Sarnico; Marina Benarese; Francesca Goffi; Alessandra Valerio; PierFranco Spano
Journal:  Eur J Neurosci       Date:  2002-12       Impact factor: 3.386

9.  Estrogen effects on high-affinity choline uptake in primary cultures of rat basal forebrain.

Authors:  Katie M Bennett; Courtney Hoelting; Christopher P Martin; James Stoll
Journal:  Neurochem Res       Date:  2008-05-16       Impact factor: 3.996

10.  Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease.

Authors:  Stephen D Ginsberg; Shaoli Che; Joanne Wuu; Scott E Counts; Elliott J Mufson
Journal:  J Neurochem       Date:  2006-03-15       Impact factor: 5.372

View more
  6 in total

1.  Chromatographic separation of reaction products from the choline acetyltransferase and carnitine acetyltransferase assay: differential ChAT and CrAT activity in brain extracts from Alzheimer's disease versus controls.

Authors:  Jason A Bailey; Debomoy K Lahiri
Journal:  J Neurochem       Date:  2012-07-02       Impact factor: 5.372

2.  Oxidative insults to neurons and synapse are prevented by aged garlic extract and S-allyl-L-cysteine treatment in the neuronal culture and APP-Tg mouse model.

Authors:  Balmiki Ray; Neelima B Chauhan; Debomoy K Lahiri
Journal:  J Neurochem       Date:  2011-03-14       Impact factor: 5.372

3.  Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc™) in the neuronal cell culture and animal model: implications for Alzheimer's disease.

Authors:  Balmiki Ray; Savita Bisht; Amarnath Maitra; Anirban Maitra; Debomoy K Lahiri
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  Choline Acetyltransferase Mutations Causing Congenital Myasthenic Syndrome: Molecular Findings and Genotype-Phenotype Correlations.

Authors:  Juan Arredondo; Marian Lara; Sídney M Gospe; Claudio G Mazia; Maria Vaccarezza; Marcela Garcia-Erro; Constance M Bowe; Celia H Chang; Michelle M Mezei; Ricardo A Maselli
Journal:  Hum Mutat       Date:  2015-07-24       Impact factor: 4.878

5.  High-affinity choline uptake (HACU) and choline acetyltransferase (ChAT) activity in neuronal cultures for mechanistic and drug discovery studies.

Authors:  Balmiki Ray; Jason A Bailey; Jay R Simon; Debomoy K Lahiri
Journal:  Curr Protoc Neurosci       Date:  2012-07

6.  Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis.

Authors:  Yazhou Li; Srinivasulu Chigurupati; Harold W Holloway; Mohamed Mughal; David Tweedie; Daniel A Bruestle; Mark P Mattson; Yun Wang; Brandon K Harvey; Balmiki Ray; Debomoy K Lahiri; Nigel H Greig
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.